Joshua Kushner - Feb 3, 2022 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Signature
/s/ Joshua Kushner
Stock symbol
OSCR
Transactions as of
Feb 3, 2022
Transactions value $
$1,196,157,778,000,000
Form type
4
Date filed
2/7/2022, 03:05 PM
Previous filing
Sep 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR 7.25% Convertible Senior Notes Award $1.2Q +34.6M $34,583,000.00* 34.6M Feb 3, 2022 Class A Common Stock 4.16M $8.32 By Thrive Capital Partners VII Growth, L.P. F1, F2, F3
transaction OSCR 7.25% Convertible Senior Notes Award $174B +417K $417,000.00* 417K Feb 3, 2022 Class A Common Stock 50.1K $8.32 By Claremount VII Associates, L.P. F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,
F2 (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.
F3 Securities held directly by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth"). Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII Growth. Joshua Kushner is the sole managing member of Thrive Partners VII Growth and, in his capacity as managing member, has voting and investment power over the securities held by Thrive VII Growth. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth except to the extent of their pecuniary interest therein.
F4 Securities held directly by Claremount VII Associates, L.P. ("Claremount VII"). Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of Thrive Partners VII and, in his capacity as managing member, has voting and investment power over the securities held by Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Claremount VII except to the extent of their pecuniary interest therein.